Pharmacokinetics and metabolism update for some recent antipsychotics.

@article{Caccia2011PharmacokineticsAM,
  title={Pharmacokinetics and metabolism update for some recent antipsychotics.},
  author={Silvio Caccia},
  journal={Expert opinion on drug metabolism & toxicology},
  year={2011},
  volume={7 7},
  pages={
          829-46
        }
}
INTRODUCTION The search for drugs that reduce psychotic symptoms, with minimal adverse effects, has led to the development of new agents that act somewhat differently from their older antipsychotic counterparts. These agents, which include aripiprazole, lurasidone and perospirone, act by targeting both D₂ and 5-HT(1A) receptors, in addition to other characteristic receptors. AREAS COVERED This article covers the pharmacokinetics and metabolism of aripiprazole, perospirone, lurasidone and… CONTINUE READING
BETA

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 102 REFERENCES

Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder

  • T SwainstonHarrison, CM Perry
  • 2004
Highly Influential
8 Excerpts

Perospirone. CNS Drugs

  • SV Onrust, K. McClellan
  • 2001
Highly Influential
6 Excerpts

Similar Papers

Loading similar papers…